
PAHC vs PCRX
$PAHC vs $PCRX head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
PAHC vs PCRX: trend, levels and the market
One year to 2026-11-16, against the S&P 500 (+11.7%). Split-adjusted daily closes.
- ·Their trends point opposite ways: PCRX is above both its 50- and 200-day averages while PAHC is below both.
- ·Only PCRX beat the market over the past year, by 38.3%, while PAHC trailed the S&P 500 at +11.7% by 27%.
- ·PCRX sits closer to its support, 0.1% above it at $36.43, while PAHC is 3.7% above its own at $32.77.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
PAHC vs PCRX: the quick read
- ·PCRX is the larger company by market cap ($1.46B vs $1.44B).
- ·PAHC has been more active on our scanner (40 vs 1 alerts in 30 days).
- ·PAHC has the smaller float (21.0M vs 37.1M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (Pharmaceutical Preparations vs PHARMACEUTICAL PREPARATIONS), so they answer to different catalysts and a move in one says little about the other.
- ·PAHC draws far more of our scanner's attention, 40 unusual-volume alerts in 30 days against 1, so it is the more actively traded of the two by some distance.
- ·They are closely matched in size, within 1% of each other on market cap, which makes the rest of this table the interesting part.
- ·They have diverged badly over the year: PCRX is near the top of its 52-week range while PAHC is near the bottom of its own.
- ·PAHC pays a dividend and PCRX does not, which usually means one is being held for income and the other for the move.
Objective differences only. Not investment advice.
Watching PAHC or PCRX? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing PAHC and PCRX on TheDesperateTrader.
- Is PAHC or PCRX the better stock?
- "Better" depends on your goal, and these two are not alike. PCRX is the larger company by market cap ($1.46B vs $1.44B). PAHC has been more active on our scanner (40 vs 1 alerts in 30 days). PAHC has the smaller float (21.0M vs 37.1M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between PAHC and PCRX?
- The differences that matter: they are not in the same business - PAHC is pharmaceutical preparations and PCRX is pharmaceutical preparations; they are similar in size ($1.44B vs $1.46B); they trade at very different share prices ($34.02 vs $36.48); PAHC sits at 18% of its 52-week range against 99% for PCRX; only PAHC pays a dividend; our scanner flagged PAHC 40 times in the last 30 days against 1 for PCRX. Everything above is measured from the latest completed session and SEC filings.
- Which of PAHC and PCRX is more active right now?
- Neither is showing unusual volume on the latest session, so nothing here is being driven by a volume spike. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is PAHC or PCRX in the stronger trend?
- PAHC is below its 50-day average of $36.68 and below its 200-day average of $41.02; PCRX is above its 50-day average of $31.39 and above its 200-day average of $25.73. PCRX leads 5 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading PAHC or PCRX? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysExplore the market
Free, live market tools. No account required to look.